# Glycemic Relapse Prevention: Maintenance Dose Assessment

> **NCT00362193** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 165 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **BEHAVIORAL:** Telephonic diabetes care

## Key facts

- **NCT ID:** NCT00362193
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 165 (—)
- **Last updated:** 2010-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362193, "Glycemic Relapse Prevention: Maintenance Dose Assessment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00362193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*